Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Sáinz, Neira ^a,d   Rodríguez, Amaia ^a,d   Catalán, Victoria ^a,d   Becerril, Sara ^a,d   Ramírez, Beatriz ^a,d   Lancha, Andoni ^a,d   Burgos Ramos, Emma ^c,d   Gómez Ambrosi, Javier ^a,d   Frühbeck, Gema ^a,b,d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; LEPTIN; MEMBRANE PROTEIN; PROTEIN TBC1D1; PROTEIN TBC1D4; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NUCLEAR PROTEIN; SLC2A4 PROTEIN, MOUSE; TBC1D1 PROTEIN, MOUSE; TBC1D4 PROTEIN, MOUSE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXTENSOR DIGITORUM LONGUS MUSCLE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; IMMUNOLOCALIZATION; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; INSULIN SENSITIVITY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SKELETAL MUSCLE; UPREGULATION; ANIMAL; C57BL MOUSE; DRUG EFFECT; GENETICS; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; METABOLOME; MOUSE MUTANT; PHOSPHORYLATION;

ANIMALIA; MUS;

ANIMALS; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; GTPASE-ACTIVATING PROTEINS; INTRACELLULAR SPACE; LEPTIN; MALE; METABOLOME; MICE; MICE, INBRED C57BL; MICE, OBESE; MUSCLE, SKELETAL; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN TRANSPORT;

EID: 84855486959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029389     Document Type: Article

References (71)

1. Huang S, Czech MP, (2007) The GLUT4 glucose transporter. Cell Metab 5: 237-252.
2. Maianu L, Keller SR, Garvey WT, (2001) Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking. J Clin Endocrinol Metab 86: 5450-5456.
3. Kane S, Sano H, Liu SC, Asara JM, Lane WS, et al. (2002) A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem 277: 22115-22118.
4. Eguez L, Lee A, Chavez JA, Miinea CP, Kane S, et al. (2005) Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab 2: 263-272.
5. Taylor EB, An D, Kramer HF, Yu H, Fujii NL, et al. (2008) Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J Biol Chem 283: 9787-9796.
6. Chadt A, Leicht K, Deshmukh A, Jiang LQ, Scherneck S, et al. (2008) Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nat Genet 40: 1354-1359.
7. Sakamoto K, Holman GD, (2008) Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am J Physiol Endocrinol Metab 295: E29-37.
8. Foster LJ, Klip A, (2000) Mechanism and regulation of GLUT-4 vesicle fusion in muscle and fat cells. Am J Physiol Cell Physiol 279: C877-890.
9. Brandie FM, Aran V, Verma A, McNew JA, Bryant NJ, et al. (2008) Negative regulation of syntaxin4/SNAP-23/VAMP2-mediated membrane fusion by Munc18c in vitro. PLoS ONE 3: e4074.
10. Frühbeck G, Gómez-Ambrosi J, (2001) Rationale for the existence of additional adipostatic hormones. FASEB J 15: 1996-2006.
11. Frühbeck G, Gómez-Ambrosi J, (2003) Control of body weight: a physiologic and transgenic perspective. Diabetologia 46: 143-172.
12. Frühbeck G, (2006) Intracellular signalling pathways activated by leptin. Biochem J 393: 7-20.
13. Anubhuti V, Arora S, (2008) Leptin and its metabolic interactions- an update. Diab Obes Metab 10: 973-993.
14. Frühbeck G, Salvador J, (2000) Relation between leptin and the regulation of glucose metabolism. Diabetologia 43: 3-12.
15. Ebihara K, Ogawa Y, Masuzaki H, Shintani M, Miyanaga F, et al. (2001) Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 50: 1440-1448.
16. Berti L, Kellerer M, Capp E, Haring HU, (1997) Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect. Diabetologia 40: 606-609.
17. Yaspelkis BB, Singh MK, Krisan AD, Collins DE, Kwong CC, et al. (2004) Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents. Life Sci 74: 1801-1816.
18. Holmes BF, Sparling DP, Olson AL, Winder WW, Dohm GL, (2005) Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am J Physiol Endocrinol Metab 289: E1071-1076.
19. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW, (1999) 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48: 1667-1671.
20. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, et al. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343.
21. Sáinz N, Rodríguez A, Catalán V, Becerril S, Ramírez B, et al. (2009) Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1α in ob/ob mice. PLoS ONE 4: e6808.
22. Wieland O, (1957) Enzymatic method for the determination of glycerin. Biochem Z 329: 313-319.
23. Alonso A, Fernández Y, Fernández R, Ordoñez P, Moreno M, et al. (2005) Effect of food restriction on the insulin signalling pathway in rat skeletal muscle and adipose tissue. J Nutr Biochem 16: 602-609.
24. Sharma N, Arias EB, Bhat AD, Sequea DA, Ho S, et al. (2011) Mechanisms for increased insulin-stimulated Akt phosphorylation and glucose uptake in fast- and slow-twitch skeletal muscles of calorie-restricted rats. Am J Physiol Endocrinol Metab 300: E966-978.
25. Ceddia R, Koistinen H, Zierath J, Sweeney G, (2002) Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 16: 1163-1176.
26. Ranganathan S, Ciaraldi TP, Henry RR, Mudaliar S, Kern PA, (1998) Lack of effect of leptin on glucose transport, lipoprotein lipase, and insulin action in adipose and muscle cells. Endocrinology 139: 2509-2513.
27. Zierath JR, Frevert EU, Ryder JW, Berggren PO, Kahn BB, (1998) Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 47: 1-4.
28. Furnsinn C, Brunmair B, Furtmuller R, Roden M, Englisch R, et al. (1998) Failure of leptin to affect basal and insulin-stimulated glucose metabolism of rat skeletal muscle in vitro. Diabetologia 41: 524-529.
29. Ceddia R, William WJ, Curi R, (1999) Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation. Int J Obes Relat Metab Disord 23: 75-82.
30. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ, (1997) Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377.
31. Muzzin P, Eisensmith RC, Copeland KC, Woo SL, (1996) Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci USA 93: 14804-14808.
32. Sweeney G, Keen J, Somwar R, Konrad D, Garg R, et al. (2001) High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells. Endocrinology 142: 4806-4812.
33. Alkhateeb H, Chabowski A, Glatz JF, Gurd B, Luiken JJ, et al. (2009) Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids. Am J Physiol Endocrinol Metab 297: E1056-E1066.
34. Berti L, Gammeltoft S, (1999) Leptin stimulates glucose uptake in C2C12 muscle cells by activation of ERK2. Mol Cell Endocrinol 157: 121-130.
35. Yaspelkis BB, Saberi M, Singh MK, Trevino B, Smith TL, (2002) Chronic leptin treatment normalizes basal glucose transport in a fiber type-specific manner in high-fat-fed rats. Metabolism 51: 859-863.
36. Tajmir P, Kwan JJ, Kessas M, Mozammel S, Sweeney G, (2003) Acute and chronic leptin treatment mediate contrasting effects on signaling, glucose uptake, and GLUT4 translocation in L6-GLUT4myc myotubes. J Cell Physiol 197: 122-130.
37. Sano H, Kane S, Sano E, Miinea CP, Asara JM, et al. (2003) Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278: 14599-14602.
38. Bruss MD, Arias EB, Lienhard GE, Cartee GD, (2005) Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54: 41-50.
39. Kramer HF, Witczak CA, Taylor EB, Fujii N, Hirshman MF, et al. (2006) AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle. J Biol Chem 281: 31478-31485.
40. Karlsson HK, Zierath JR, Kane S, Krook A, Lienhard GE, et al. (2005) Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 54: 1692-1697.
41. Vind BF, Pehmoller C, Treebak JT, Birk JB, Hey-Mogensen M, et al. (2011) Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. Diabetologia 54: 157-167.
42. Chen S, Wasserman DH, MacKintosh C, Sakamoto K, (2011) Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell Metab 13: 68-79.
43. Larance M, Ramm G, Stockli J, van Dam EM, Winata S, et al. (2005) Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem 280: 37803-37813.
44. Chavez JA, Roach WG, Keller SR, Lane WS, Lienhard GE, (2008) Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation. J Biol Chem 283: 9187-9195.
45. Karlsson HK, Chibalin AV, Koistinen HA, Yang J, Koumanov F, et al. (2009) Kinetics of GLUT4 trafficking in rat and human skeletal muscle. Diabetes 58: 847-854.
46. Funai K, Cartee GD, (2009) Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle. Diabetes 58: 1096-1104.
47. Frosig C, Pehmoller C, Birk JB, Richter EA, Wojtaszewski JF, (2010) Exercise-induced TBC1D1 Ser237 phosphorylation and 14-3-3 protein binding capacity in human skeletal muscle. J Physiol 588: 4539-4548.
48. Gaidhu MP, Perry RL, Noor F, Ceddia RB, (2010) Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes. Mol Endocrinol 24: 1434-1440.
49. Jessen N, Pold R, Buhl ES, Jensen LS, Schmitz O, et al. (2003) Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 94: 1373-1379.
50. Jessen N, An D, Lihn AS, Nygren J, Hirshman MF, et al. (2011) Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 301: E164-171.
51. Breen L, Philp A, Shaw CS, Jeukendrup AE, Baar K, et al. (2011) Beneficial effects of resistance exercise on glycemic control are not further improved by protein ingestion. PLoS ONE 6: e20613.
52. Stefanyk LE, Gulli RA, Ritchie IR, Chabowski A, Snook LA, et al. (2011) Recovered insulin response by 2 weeks of leptin administration in high-fat fed rats is associated with restored AS160 activation and decreased reactive lipid accumulation. Am J Physiol Regul Integr Comp Physiol 301: R159-171.
53. Manco M, Calvani M, Mingrone G, (2004) Effects of dietary fatty acids on insulin sensitivity and secretion. Diab Obes Metab 6: 402-413.
54. Stuart CA, Wen G, Williamson ME, Jiang J, Gilkison CR, et al. (2001) Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4: protein in muscle from patients with acanthosis nigricans and severe insulin resistance. Metabolism 50: 771-777.
55. Cheng IS, Lee NY, Liu KL, Liao SF, Huang CH, et al. (2005) Effect of postexercise carbohydrate supplementation on glucose uptake-associated gene expression in the human skeletal muscle. J Nutr Biochem 16: 267-271.
56. Funai K, Schweitzer GG, Sharma N, Kanzaki M, Cartee GD, (2009) Increased AS160 phosphorylation, but not TBC1D1 phosphorylation, with increased postexercise insulin sensitivity in rat skeletal muscle. Am J Physiol Endocrinol Metab 297: E242-251.
57. Wang JL, Chinookoswong N, Scully S, Qi M, Shi ZQ, (1999) Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology 140: 2117-2124.
58. Wright DC, Hucker KA, Holloszy JO, Han DH, (2004) Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 53: 330-335.
59. Wright DC, Geiger PC, Holloszy JO, Han DH, (2005) Contraction- and hypoxia-stimulated glucose transport is mediated by a Ca2+-dependent mechanism in slow-twitch rat soleus muscle. Am J Physiol Endocrinol Metab 288: E1062-1066.
60. Marette A, Richardson JM, Ramlal T, Balon TW, Vranic M, et al. (1992) Abundance, localization, and insulin-induced translocation of glucose transporters in red and white muscle. Am J Physiol 263: C443-452.
61. Stuart CA, Wen G, Peng BH, Popov VL, Hudnall SD, et al. (2000) GLUT-3 expression in human skeletal muscle. Am J Physiol Endocrinol Metab 279: E855-861.
62. Stuart CA, Yin D, Howell ME, Dykes RJ, Laffan JJ, et al. (2006) Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle. Am J Physiol Endocrinol Metab 291: E1067-1073.
63. Stuart CA, Howell ME, Zhang Y, Yin D, (2009) Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle. J Clin Endocrinol Metab 94: 3535-3542.
64. Sakar Y, Nazaret C, Letteron P, Ait Omar A, Avenati M, et al. (2009) Positive regulatory control loop between gut leptin and intestinal GLUT2/GLUT5 transporters links to hepatic metabolic functions in rodents. PLoS ONE 4: e7935.
65. Gaster M, Poulsen P, Handberg A, Schroder HD, Beck-Nielsen H, (2000) Direct evidence of fiber type-dependent GLUT-4 expression in human skeletal muscle. Am J Physiol Endocrinol Metab 278: E910-916.
66. Gaster M, Staehr P, Beck-Nielsen H, Schroder HD, Handberg A, (2001) GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes 50: 1324-1329.
67. Benomar Y, Naour N, Aubourg A, Bailleux V, Gertler A, et al. (2006) Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase- dependent mechanism. Endocrinology 147: 2550-2556.
68. Borghouts LB, Schaart G, Hesselink MK, Keizer HA, (2000) GLUT-4 expression is not consistently higher in type-1 than in type-2 fibres of rat and human vastus lateralis muscles; an immunohistochemical study. Pflugers Arch 441: 351-358.
69. Shi J, Kandror KV, (2005) Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes. Dev Cell 9: 99-108.
70. Ariga M, Nedachi T, Katagiri H, Kanzaki M, (2008) Functional role of sortilin in myogenesis and development of insulin-responsive glucose transport system in C2C12 myocytes. J Biol Chem 283: 10208-10220.
71. Kaddai V, Jager J, González T, Najem-Lendom R, Bonnafous S, et al. (2009) Involvement of TNF-α in abnormal adipocyte and muscle sortilin expression in obese mice and humans. Diabetologia 52: 932-940.